NVST has a higher Zacks Rank (#2 Buy vs #3 Hold), better Value grade (B vs C), lower forward P/E ratio (17.51 vs 19.11), lower PEG ratio (1.28 vs 1.96), and lower P/B ratio (1.42 vs 3.53), indicating stronger earnings outlook and more attractive valuation metrics for value investors.
Zacks Rank #1 with Value Score B, strong 13.7% five-year expected growth rate, and diversified dental solutions portfolio providing long-term growth potential at attractive valuation.
Identified as a key market player positioned to capitalize on the expanding dental laboratories market and increasing adoption of advanced technologies.
Articles that tag NVST but are mainly about other companies.
Zacks Rank #1 rating, P/E of 15.25 significantly below industry average (38.30), Value Score B, and 7.8% earnings estimate increase support positive investment thesis.
Reported 5.0% core sales growth, demonstrating stronger relative performance in the dental industry. Zacks Rank #1 (Strong Buy) indicates positive outlook.
Listed as a major player in the dental imaging equipment market, which is experiencing robust growth with 7.1% CAGR through 2031, driven by technological advancements and increasing demand for advanced imaging solutions.
Identified as a key market player positioned to benefit from the rapidly expanding clear aligners market, particularly through digital dentistry solutions and advanced orthodontic technologies.
Articles and sentiment ratings from Massive / Polygon. Sentiment is the provider's model rating for this company, not Gainbot's view.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology
